Key result
Metabolic syndrome was associated with an increased 5-year incidence of fatal and nonfatal coronary heart disease compared to controls (8% vs. 3%; P=0.012).
Why the study?
Does metabolic syndrome increase the risk of progressive carotid atherosclerosis and incident coronary heart disease in adults aged 40-79 years?
Cohort (n=888)
Does metabolic syndrome increase the risk of progressive carotid atherosclerosis and incident coronary heart disease in adults aged 40-79 years?
Absolute Event Rate: 8% vs 3%
p-value: p=0.012
Metabolic syndrome is associated with a significantly increased 5-year risk of progressive carotid atherosclerosis and incident coronary heart disease.
No takes yet. Share an insight, caveat, or question.
Supports metabolic syndrome for CHD risk stratification in adults 40-79; leaves open independent effects on carotid atherosclerosis progression.
Bonora et al. (2003) conducted a cohort in Metabolic syndrome (n=888). Metabolic syndrome vs. Control subjects (without metabolic syndrome) was evaluated on Incident fatal and nonfatal coronary heart disease (p=0.012). Metabolic syndrome was associated with an increased 5-year incidence of fatal and nonfatal coronary heart disease compared to controls (8% vs. 3%; P=0.012).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: